Fluticasone furoate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Fluticasone furoate is {{{aOrAn}}} Anti-Allergic Agents that is FDA approved for the treatment of It is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older.. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
The recommended starting dosage is 110 mcg once daily administered as 2 sprays (27.5 mcg/spray) in each nostril. When the maximum benefit has been achieved and symptoms have been controlled, reducing the dosage to 55 mcg (1 spray in each nostril) once daily may be effective in maintaining control of allergic rhinitis symptoms.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Fluticasone furoate in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Fluticasone furoate in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
The recommended starting dosage in children is 55 mcg once daily administered as 1 spray (27.5 mcg/spray) in each nostril. Children not adequately responding to 55 mcg may use 110 mcg (2 sprays in each nostril) once daily. Once symptoms have been controlled, dosage reduction to 55 mcg once daily is recommended.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Fluticasone furoate in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Fluticasone furoate in pediatric patients.
Contraindications
Fluticasone furoate is contraindicated in patients with hypersensitivity to any of its ingredients
Warnings
There is limited information regarding Fluticasone furoate Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Fluticasone furoate Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Fluticasone furoate Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Fluticasone furoate Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Fluticasone furoate in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Fluticasone furoate in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Fluticasone furoate during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Fluticasone furoate in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Fluticasone furoate in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Fluticasone furoate in geriatric settings.
Gender
There is no FDA guidance on the use of Fluticasone furoate with respect to specific gender populations.
Race
There is no FDA guidance on the use of Fluticasone furoate with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Fluticasone furoate in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Fluticasone furoate in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Fluticasone furoate in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Fluticasone furoate in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Fluticasone furoate Administration in the drug label.
Monitoring
There is limited information regarding Fluticasone furoate Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Fluticasone furoate and IV administrations.
Overdosage
There is limited information regarding Fluticasone furoate overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Fluticasone furoate Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Fluticasone furoate Mechanism of Action in the drug label.
Structure
There is limited information regarding Fluticasone furoate Structure in the drug label.
Pharmacodynamics
There is limited information regarding Fluticasone furoate Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Fluticasone furoate Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Fluticasone furoate Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Fluticasone furoate Clinical Studies in the drug label.
How Supplied
There is limited information regarding Fluticasone furoate How Supplied in the drug label.
Storage
There is limited information regarding Fluticasone furoate Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Fluticasone furoate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Fluticasone furoate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Fluticasone furoate Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Fluticasone furoate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Fluticasone furoate Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Fluticasone furoate Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.